AstraZeneca Sues 4 Drugmakers To Stop Generic Vimovo
AstraZeneca on Thursday sued three pharmaceutical companies — Dr. Reddy’s Laboratories Inc., Lupin Ltd. and Actavis Inc. — and another, Mylan Pharmaceuticals, on Wednesday, to stop generic forms of Vimovo from entering the market after the companies filed multiple abbreviated new drug applications with the U.S. Food and Drug Administration.
The suits center on U.S. Patent No. 8,557,285, entitled “Pharmaceutical...
To view the full article, register now.